NCT07543068

Brief Summary

This study is being done to find better ways to help people with prediabetes prevent or delay the development of type 2 diabetes. Prediabetes means your blood sugar is higher than normal, but not high enough to be diagnosed with diabetes. It is often silent, but without changes in diet and activity, many people progress to a diagnosis of diabetes within a few years. The study combines two strategies:

  1. 1.Group visits - small, regular meetings where patients learn about healthy eating, physical activity, and stress management.
  2. 2.Continuous Glucose Monitors (CGMs) - small wearable sensors that measure blood sugar all day and show how food, movement, and sleep affect it in real time.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Apr 2026Dec 2026

Study Start

First participant enrolled

April 1, 2026

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 21, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 21, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

April 15, 2026

Last Update Submit

April 15, 2026

Conditions

Keywords

CGMPre DiabetesElevated sugarHyperglycemiaHyperglycaemiaInterventions

Outcome Measures

Primary Outcomes (1)

  • That pairing real-time physiologic feedback from CGMs with the structured curriculum, peer accountability, and multidisciplinary support will facilitate meaningful lifestyle changes and better metabolic control in this population.

    Among patients with prediabetes, does participation in a program that integrates CGMs with group meetings lead to improvements in clinical outcomes such as fasting glucose, HbA1c, and weight compared to baseline measures? Does the combined use of CGMs and SMAs enhance psychosocial outcomes such as self-efficacy, readiness to change, and adherence to lifestyle modifications in patients with prediabetes? Does the integration of CGMs into lifestyle change program increase participant engagement and attendance compared to program alone?

    25 weeks

Study Arms (1)

SMART

EXPERIMENTAL

The intervention combines group sessions and CGM-based behavioral feedback. Group sessions will occur twice in month 1 and monthly thereafter at the SHSU clinic and will cover nutrition, movement, stress, sleep and habit formation. Study investigators will prepare and coordinate each meeting; additional presenters include a nutritionist, an exercise specialist (activity planning), and a behavioral health clinician. Participants will be using CGMs during the weeks 3-6 and 13-14 or 13-16.

Other: Combines group sessions and CGM-based behavioral feedback

Interventions

The study combines two strategies: 1. Group visits - small, regular meetings where patients learn about healthy eating, physical activity, and stress management. 2. Continuous Glucose Monitors (CGMs) - small wearable sensors that measure blood sugar all day and show how food, movement, and sleep affect it in real time. By bringing these two tools together, the research hopes to help participants better understand their own bodies and make lasting lifestyle changes.

SMART

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Prediabetes by a physician based on A1c, fasting glucose or American Diabetes Association (ADA) Type 2 risk test.
  • to 75 years old inclusive.

You may not qualify if:

  • Non-English-Speaking individuals.
  • Diagnosed with Diabetes.
  • Use of glucose lowering medications (GLP-1, Metformin, etc.)
  • Pregnant women.
  • Unwilling to use Continuous Glucose Monitors (CGMs)
  • Unable to assist to the Group meetings in Conroe, TX.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

SHSU College of Osteopathic Medicine

Conroe, Texas, 77304, United States

Location

SHSU Physician's Clinic

Conroe, Texas, 77304, United States

Location

Related Publications (1)

  • 1. Richardson, K. M., Schembre, S. M., da Silva, V., Blew, R. M., Behrens, N., Roe, D. J., Marvasti, F. F., & Hingle, M. (2024). Adding a Brief Continuous Glucose Monitoring Intervention to the National Diabetes Prevention Program: A Multimethod Feasibility Study. Journal of diabetes research, 2024, 7687694. https://doi.org/10.1155/2024/7687694 2. Zahalka, S. J., Akturk, H. K., Galindo, R. J., Shah, V. N., & Low Wang, C. C. (2025). Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 31(8), 1054-1060. https://doi.org/10.1016/j.eprac.2025.05.742 3. Ahn, Y. C., Kim, Y. S., Kim, B., Ryu, J. M., Kim, M. S., Kang, M., & Park, J. (2023). Effectiveness of Non-Contact Dietary Coaching in Adults with Diabetes or Prediabetes Using a Continuous Glucose Monitoring Device: A Randomized Controlled Trial. Healthcare (Basel, Switzerland), 11(2), 252. https://doi.org/10.3390/healthcare11020252 4. Portal Teixeira, P., Pozzer Zucatti, K., Strassburger Matzenbacher, L., Fink Wayerbacher, L., Zhang, M., Colpani, V., & Gerchman, F. (2024). Long-term lifestyle intervention can reduce the development of type 2 diabetes mellitus in subjects with prediabetes: A systematic review and meta-analysis. Diabetes research and clinical practice, 210, 111637. https://doi.org/10.1016/j.diabres.2024.111637

    BACKGROUND

MeSH Terms

Conditions

Glucose IntoleranceHyperglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2026

First Posted

April 21, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 21, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations